<DOC>
	<DOCNO>NCT00170768</DOCNO>
	<brief_summary>The purpose study explore possible cognitive effect darifenacin modified release long-acting oxybutynin .</brief_summary>
	<brief_title>Cognitive Effects Darifenacin Oxybutynin Extended Release Volunteers Aged 60 Over</brief_title>
	<detailed_description />
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Males female age 60 United States English primary language Given write informed consent sign date informed consent form prior study entry Current diseases use anticholinergic drug contraindicate , include use drug anticholinergic effect Volunteers history urinary retention current bladder outlet obstruction , determine investigator Other protocol define inclusion/exclusion criterion may apply . Current use drug know effect memory cognition Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Darifenacin , oxybutynin , cognition , memory</keyword>
</DOC>